Par Pharmaceutical Companies, Inc. Company Profile

Aggregated data from the web about Par Pharmaceutical Companies, Inc.

Company Name	Par Pharmaceutical Companies, Inc.
Website	endo.com
Snippet	Endo International plc is an Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.[1][2][3]
ISIN	IE00BJ3V9050
Type	public liability company
Founded	1997
Revenue	US$ 3,468.8 million (2017)
Website	endo.com
Industry	Pharmaceutical
Traded as	NASDAQ: ENDP, S&P 600 component
Key people	Paul Campanelli (CEO), Blaise Coleman (CFO)
Predecessor	Endo Pharmaceuticals Inc. (before the 2014 tax inversion to Ireland)
Headquarters	(Legal) Dublin, Ireland, (Operational) Malvern, Pennsylvania, United States.

Par Pharmaceutical Companies, Inc. is part of the Ireland company list

Par Pharmaceutical Companies, Inc. is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.